Literature DB >> 19699545

Oral cavity squamous cell carcinoma in 260 patients aged 80years or more.

Cécile Ortholan1, Antoine Lusinchi, Antoine Italiano, René-Jean Bensadoun, Anne Auperin, Gilles Poissonnet, Alexandre Bozec, Rodrigo Arriagada, Stéphane Temam, Karen Benezery, Juliette Thariat, Yungan Tao, François Janot, Gérard Mamelle, Jacques Vallicioni, Philippe Follana, Frédéric Peyrade, Anne Sudaka, Jean Bourhis, Olivier Dassonville.   

Abstract

PURPOSE: We report the experience of two French cancer centers in the treatment of oral cavity squamous cell carcinoma (SCC) in patients aged 80 years.
MATERIALS AND METHODS: Two hundred and sixty patients aged 80 years with a primary oral cavity SCC were included in this retrospective analysis.
RESULTS: Sex ratio was near to 1. Tobacco or alcohol intoxication was the main risk factor for 66% of men and 16% of women and leukoplakia, lichen planus, or oral traumatism for 55% of women and 11% of men (p<0.0001). Two hundred patients received a loco-regional (LR) treatment with a curative intent (surgery and/or radiotherapy), 29 with a palliative intent and 31 did not receive a LR treatment. Curative treatments were initially planned to be adapted to age in 118 patients (59%). The median disease-specific survival (DSS) was 29 months. In multivariate analysis, the independent prognostic factors for DSS were stage (HR=0.42 [0.24-0.72]), age (HR=0.43 [0.24-0.75]) and performance status (HR=0.50 [0.27-0.95]). The median overall survival (OS) was 14 months. In multivariate analysis, the independent prognostic factors for OS were age (HR=0.52 [0.35-0.79]), stage (HR=0.56 [0.38-0.84]), tumor differentiation (HR=0.60 [0.33-0.93]) and performance status (HR=0.6 [0.37-0.97]). In patients treated with a curative intent, treatment adapted to age was not associated with a decreased overall survival or disease-specific survival as compared with the standard treatment. However, prophylactic lymph node treatment in stages I-II tumors decreased the rate of nodal recurrence from 38% to 6% (p=0.01).
CONCLUSION: This study emphasizes the need for prospective evaluation of standard and adapted schedules in elderly patients with oral cavity cancer.

Entities:  

Mesh:

Year:  2009        PMID: 19699545     DOI: 10.1016/j.radonc.2009.07.015

Source DB:  PubMed          Journal:  Radiother Oncol        ISSN: 0167-8140            Impact factor:   6.280


  5 in total

Review 1.  Optimal management of the elderly patient with head and neck cancer: Issues regarding surgery, irradiation and chemotherapy.

Authors:  Giannis Mountzios
Journal:  World J Clin Oncol       Date:  2015-02-10

Review 2.  Squamous cell carcinoma of the head and neck in the elderly.

Authors:  Jasenka Gugić; Primož Strojan
Journal:  Rep Pract Oncol Radiother       Date:  2012-08-10

3.  [Head and neck cancer in the elderly-current aspects].

Authors:  B Höing; S Lang; M Stuschke; S Hansen
Journal:  HNO       Date:  2020-03       Impact factor: 1.284

4.  Mortality in tongue cancer patients treated by curative surgery: a retrospective cohort study from CGRD.

Authors:  Ming-Shao Tsai; Chia-Hsuan Lai; Chuan-Pin Lee; Yao-Hsu Yang; Pau-Chung Chen; Chung-Jan Kang; Geng-He Chang; Yao-Te Tsai; Chang-Hsien Lu; Chih-Yen Chien; Chi-Kuang Young; Ku-Hao Fang; Chin-Jui Liu; Re-Ming A Yeh; Wen-Cheng Chen
Journal:  PeerJ       Date:  2016-12-15       Impact factor: 2.984

Review 5.  Treatment of Elderly Patients with Squamous Cell Carcinoma of the Head and Neck.

Authors:  Petr Szturz; Jan B Vermorken
Journal:  Front Oncol       Date:  2016-08-31       Impact factor: 6.244

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.